Skip to content
healthcare.dev

Regadenoson

NDC 0409-1401, Regadenoson, injection, solution, from Hospira, Inc..

Product NDC
0409-1401
Status
Listed
Labeler
Hospira, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214349
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1401 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REGADENOSON ANHYDROUS.08 mg/mL

Pharmacologic classes

Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]

Package NDCNDC-11Package
0409-1401-010040914010110 CARTON in 1 PACKAGE (0409-1401-01) / 1 SYRINGE, PLASTIC in 1 CARTON / 5 mL in 1 SYRINGE, PLASTIC (0409-1401-05)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0e3f080d-b1fb-47ed-8cd3-90a4206fa704
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0409-1401

Use it

Look up 0409-1401 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1401 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0409-1401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.